Teva Pharmaceutical Industries Limited - Financial and Strategic Analysis Review

Summary

Teva Pharmaceutical Industries Limited - Financial and Strategic Analysis Review

Summary

Teva Pharmaceutical Industries Limited (Teva), a global pharmaceutical company, is engaged in the development, manufacturing and commercialization of generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients (API). The company offers its broad product portfolio of pharmaceutical, healthcare, biopharmaceutical product in over 60 countries across the globe. The production facilities are based in Israel, Europe, North America and Latin America. The company is headquartered in Tikva, Israel. In 2009, the company launched Topamax Tablets, Adderall XR and Generic Urso 250. It also received approval of Risperdal oral solution, Copaxone and Imitrex Tablets.

Global Markets Direct's Teva Pharmaceutical Industries Limited - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Teva Pharmaceutical Industries Limited. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

• Provides key company information for business intelligence needs.
• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and financial and strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitor's weaknesses and target the market opportunities available to them.
• Compare your company's financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

• List of Tables
• List of Figures
  • Teva Pharmaceutical Industries Limited - Key Facts
  • Teva Pharmaceutical Industries Limited - Business Description
  • Teva Pharmaceutical Industries Limited - Major Products and Services
  • Teva Pharmaceutical Industries Limited - History
  • Teva Pharmaceutical Industries Limited - SWOT Analysis
  • SWOT Analysis - Overview
  • Teva Pharmaceutical Industries Limited - Strengths
  • Strength - Strategic Acquisitions
  • Strength - Strong Financial Performance
  • Strength - Leading Multiple Sclerosis Product
  • Strength - Global Presence
  • Teva Pharmaceutical Industries Limited - Weaknesses
  • Weakness - Rise in Selling and Marketing Expenditure
  • Weakness - Lawsuits
  • Teva Pharmaceutical Industries Limited - Opportunities
  • Opportunity - Entry to Japanese Market
  • Opportunity - Patent Expirations of Blockbuster Drugs
  • Opportunity - Growing Importance of Generics
  • Opportunity - Strategic Alliance with Lonza
  • Opportunity - Product Approval and Launches
  • Opportunity - Fast Track Designation for Oral Laquinimod
  • Teva Pharmaceutical Industries Limited - Threats
  • Threat - Industry Regulations
  • Threat - Rising Price Pressure
  • Threat - Competition
  • Threat - Increased Scrutiny on Drug Imports
  • Threat - Counterfeit Drugs
  • Teva Pharmaceutical Industries Limited - Key Competitors
  • Teva Pharmaceutical Industries Limited - Key Employees
  • Teva Pharmaceutical Industries Limited - Key Employee Biographies
  • Teva Pharmaceutical Industries Limited - Company Statement
  • Teva Pharmaceutical Industries Limited - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Teva Pharmaceutical Industries Limited - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Appendix
  • Methodology
  • Ratio Definitions
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • Teva Pharmaceutical Industries Limited, Key Facts
  • Teva Pharmaceutical Industries Limited, Major Products and Services
  • Teva Pharmaceutical Industries Limited, History
  • Teva Pharmaceutical Industries Limited, Key Employees
  • Teva Pharmaceutical Industries Limited, Key Employee Biographies
  • Teva Pharmaceutical Industries Limited, Other Locations
  • Teva Pharmaceutical Industries Limited, Subsidiaries
  • Teva Pharmaceutical Industries Limited, Ratios based on current share price
  • Teva Pharmaceutical Industries Limited, Annual Ratios
  • Teva Pharmaceutical Industries Limited, Interim Ratios
• List of Figures
  • Teva Pharmaceutical Industries Limited, Ratio Charts